BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10858190)

  • 21. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
    J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urokinase and urokinase receptor participate in regulation of neuronal migration, axon growth and branching.
    Semina E; Rubina K; Sysoeva V; Rysenkova K; Klimovich P; Plekhanova O; Tkachuk V
    Eur J Cell Biol; 2016 Sep; 95(9):295-310. PubMed ID: 27324124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor.
    Shanmukhappa K; Sabla GE; Degen JL; Bezerra JA
    BMC Gastroenterol; 2006 Nov; 6():40. PubMed ID: 17134505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of ICAM-1 (CD54) in the development of murine cerebral malaria.
    Favre N; Da Laperousaz C; Ryffel B; Weiss NA; Imhof BA; Rudin W; Lucas R; Piguet PF
    Microbes Infect; 1999 Oct; 1(12):961-8. PubMed ID: 10617927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased bone formation in mice lacking plasminogen activators.
    Daci E; Everts V; Torrekens S; Van Herck E; Tigchelaar-Gutterr W; Bouillon R; Carmeliet G
    J Bone Miner Res; 2003 Jul; 18(7):1167-76. PubMed ID: 12854826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
    Zhang G; Cai X; López-Guisa JM; Collins SJ; Eddy AA
    J Am Soc Nephrol; 2004 Aug; 15(8):2090-102. PubMed ID: 15284295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection.
    Gyetko MR; Sud S; Kendall T; Fuller JA; Newstead MW; Standiford TJ
    J Immunol; 2000 Aug; 165(3):1513-9. PubMed ID: 10903758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of urokinase-type plasminogen activator and its receptor in gastric fibroblasts and effects of nonsteroidal antiinflammatory drugs and prostaglandin.
    Iwamoto J; Takahashi K; Mizokami Y; Otsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokoube K; Matsuoka T
    Dig Dis Sci; 2003 Dec; 48(12):2247-56. PubMed ID: 14714609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
    Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
    J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
    Mahanivong C; Yu J; Huang S
    Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings.
    Friess H; Duarte R; Kleeff J; Fukuda A; Tang WH; Graber H; Schilling M; Zimmermann A; Korc M; Büchler MW
    Surgery; 1998 Jul; 124(1):79-86. PubMed ID: 9663255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator.
    Schäfer K; Konstantinides S; Riedel C; Thinnes T; Müller K; Dellas C; Hasenfuss G; Loskutoff DJ
    Circulation; 2002 Oct; 106(14):1847-52. PubMed ID: 12356640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.
    Quax PH; Grimbergen JM; Lansink M; Bakker AH; Blatter MC; Belin D; van Hinsbergh VW; Verheijen JH
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):693-701. PubMed ID: 9598826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87).
    Longstaff C; Merton RE; Fabregas P; Felez J
    Blood; 1999 Jun; 93(11):3839-46. PubMed ID: 10339491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway.
    Oka H; Kugiyama K; Doi H; Matsumura T; Shibata H; Miles LA; Sugiyama S; Yasue H
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):244-50. PubMed ID: 10634825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urokinase-type plasminogen activator deficiency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms.
    Uchida HA; Poduri A; Subramanian V; Cassis LA; Daugherty A
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2845-52. PubMed ID: 21868698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target.
    McGuire PG; Jones TR; Talarico N; Warren E; Das A
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2736-42. PubMed ID: 12766081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor.
    Mori T; Abe T; Wakabayashi Y; Hikawa T; Matsuo K; Yamada Y; Kuwano M; Hori S
    J Neurooncol; 2000; 46(2):115-23. PubMed ID: 10894364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity.
    Huang S; New L; Pan Z; Han J; Nemerow GR
    J Biol Chem; 2000 Apr; 275(16):12266-72. PubMed ID: 10766865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.